Niagen Bioscience, Inc.
Pharmaceutical company · Los Angeles, California, United States · Nasdaq: NAGE
Niagen Bioscience, Inc. is a pharmaceutical company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2008. Its shares trade on Nasdaq under the ticker NAGE. It has reported private securities offerings to the US SEC, most recently $3.1 million sold in a notice filed in 2022.
Niagen Bioscience at a glance
What does Niagen Bioscience do?
Private fundraising reported to the SEC
15 Form D notices; the most recent reported $3.1 million sold (2022).
Frequently asked questions about Niagen Bioscience
Where is Niagen Bioscience headquartered?
Niagen Bioscience, Inc. is headquartered in Los Angeles, California, United States.
What does Niagen Bioscience do?
Niagen Bioscience, Inc. is a pharmaceutical company. Its SEC industry classification is Medicinal Chemicals & Botanical Products.
Is Niagen Bioscience a public company?
Yes. Niagen Bioscience, Inc. trades on Nasdaq under the ticker NAGE.
When was Niagen Bioscience founded?
The earliest incorporation on record for Niagen Bioscience, Inc. is in 2008, according to public company registers.
Similar companies
- Puma Biotechnology, Inc.Los Angeles, California, United States
- Capricor IncLos Angeles, California, United States
- Immix Biopharma, Inc.Los Angeles, California, United States
- Lunai Bioworks Inc.Los Angeles, California, United States
- Avenzoar Pharmaceuticals, Inc.Los Angeles, California, United States
- Targeted Medical Pharma, Inc.Los Angeles, California, United States
- Kairos Pharma, LTD.Los Angeles, California, United States
- Pelage Pharmaceuticals, Inc.Los Angeles, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences